News | News By Subject | News by Disease News By Date | Search News

Alzheimer's Disease News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Why Former Medivation (MDVN) CEO and a Once-Failed Alzheimer's Drug Could be a Recipe for Disaster for Axovant (AXON)     4/20/2017
Bristol-Myers Squibb (BMY) Inks Two Separate Pacts With Biogen (BIIB) and Roche (RHHBY) For a Total of Up to $1.1B     4/14/2017
A Look at Biogen (BIIB)'s Big Bet on the Holy Grail of Science—Alzheimer's     3/29/2017
Why This Alzheimer's Biotech May Not Live to See 2020     3/6/2017
Merck & Co. (MRK), Eli Lilly (LLY) Failure Puts Alzheimer's Drug Development Spotlight on Rival Genentech (RHHBY)     3/1/2017
After Merck & Co. (MRK) & Eli Lilly (LLY) Alzheimer’s Failures, A Look at 7 Companies Still on the Hunt     2/20/2017
Another Drug Bites the Dust: Merck & Co. (MRK) Stops Late-Stage Alzheimer’s Study     2/16/2017
2 Biotechs Taking on the $20 Billion Alzheimer's Market Full Force     2/15/2017
H. Lundbeck A/S (LUN.CO) Throws in the Towel on Alzheimer's Pill, Giving Leeway to Rival Axovant (AXON)     2/8/2017
Eli Lilly (LLY) Washes Its Hands of Another Phase 3 Study After the Failure of Solanezumab     2/2/2017
The 7 Worst Clinical Disasters of 2016     12/27/2016
Acadia (ACAD) Stock Screams Upward; Primary Endpoint Met in Phase II Study of Pimavanserin for Alzheimer’s     12/21/2016
Investors Sigh With Relief as Biogen (BIIB)'s Alzheimer's Drug Delivers in Early-Stage Study     12/15/2016
As Biogen (BIIB)'s Drug Shines, Eli Lilly (LLY) Releases Detailed Results of Its Own Failure Solanezumab     12/9/2016
All Eyes Will Be on Biogen (BIIB) and Its Much-Anticipated Alzheimer's Data Tomorrow     12/9/2016

News from Around the Web
Hopes Up On Lasers Kindling Lost Memories In Alzheimer’s Patients, MIT Reveals     3/31/2017
New Test May Predict Onset Of Alzheimer's, UCSF Study Reveals     3/22/2017
How This Biotech Phenom Plans To Speed Up Drug Research And Cure Alzheimer's     3/8/2017
Will BACE Inhibitors Help Alzheimer's Patients?     2/24/2017
Merck & Co. (MRK)'s Alzheimer's Failure Has All Eyes and Hopes Turning to Biogen (BIIB)     2/16/2017
Alzheimer's Causes: Could Refined Sugar Lead To Dementia, Cognitive Decline?     2/14/2017
6 Unexpected Ways To Decrease Your Risk Of Alzheimer’s     2/13/2017
NeuroEM Medical Device Could Be Major Breakthrough For People With Alzheimer's, Banner Health Study Reveals     2/1/2017
From Psychedelics To Alzheimer's, 2016 Was A Good Year For Brain Science     1/3/2017
Following Eli Lilly (LLY)'s Failure, What's Next In Alzheimer's Treatments?     12/19/2016
Treating Alzheimer’s Disease With Brain Waves, Study Published In Nature     12/9/2016
Catalyst Driver For PDL BioPharma (PDLI) Is Coming     11/18/2016
Alzheimer’s Didn’t Cause Memory Loss For These Superaging 90-Year Olds, Northwestern University Feinberg School of Medicine Study     11/17/2016
Eli Lilly (LLY)'s Solanezumab And The History Of The Future Of Treating Alzheimer's Disease     11/11/2016
Baylor College of Medicine Take First Steps Toward A Preventative Alzheimer's Pill     10/25/2016

Press Releases
Funding From Alzheimer's Drug Discovery Foundation Advances M3 Biotechnology Toward Human Trials     4/14/2017
Dthera Sciences (DTHR) Announces Results Of Clinical Study Of Its Product ReminX     4/10/2017
Probiodrug AG Release: Last Patient Last Visit (LPLV) Reached In The SAPHIR Study     4/7/2017
Hopes Up On Lasers Kindling Lost Memories In Alzheimer’s Patients, MIT Reveals     3/31/2017
Alzheon Presents Data To Support Selection Of Patients With Mild Alzheimer’s Disease For Pivotal Study Of ALZ-801 Using Precision Medicine Approach     3/30/2017
PHARNEXT To Present New PXT864 Synergy Data At AD/PDTM 2017, The 13th International Conference On Alzheimer's And Parkinson's Diseases And Related Neurological Disorders     3/29/2017
New Test May Predict Onset Of Alzheimer's, UCSF Study Reveals     3/22/2017
Amydis Diagnostics, Inc. Awarded NIH Grant To Further Investigate Innovative Technology For Early Detection Of Alzheimer’s Disease     3/20/2017
Biogen (BIIB) Puts E-Scape Bio Vet on Payroll to Tackle Neurodegenerative Diseases Like Alzheimer's     3/16/2017
Longeveron Achieves Milestone In Groundbreaking Stem Cell Trial For Alzheimer's Disease     3/16/2017
Asuragen, Inc. Launches The Amplidex PCR/CE TOMM40 Kit1 Expanding Portfolio Into The Alzheimer’s And Cognitive Impairment Space     3/14/2017
Nature Cell Started Commercial Clinical Trials Phase I And II "ASTROSTEM," Stem Cell Drug For Alzheimer's Disease Treatment In U.S.     3/10/2017
Not Giving Up: Roche (RHHBY) To Start New Phase III Tests With Once-Failed Alzheimer's Drug     3/7/2017
Neurim Pharmaceuticals Release: Phase II Clinical Trial For Treatment Of Mild Alzheimer's Disease     3/7/2017
Buck Institute for Age Research Release: The Bredesen Protocol Announces Progress In Reversal Of Cognitive Decline In Alzheimer’s Disease     3/6/2017